Maximum ultrafiltration rate in continuous arteriovenous hemofiltration does not occur at the lowest level of the ultrafiltrate collection chamber

Randall Jenkins, B. Chen, J. E. Funk

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A common assumption is that increasing transmembrane pressure by lowering the ultrafiltrate receptacle and the accompanying fluid column should always result in increasing ultrafiltration in continuous arteriovenous hemofiltration (CAVH) systems. To test this assumption, CAVH circuits were operated in vitro with use of a recirculating apparatus with an adjustable elevated reservoir. Hydraulic operational characteristics were studied in a variety of CAVH circuits, lowering the height of the ultrafiltrate column stepwise until it was at the lowest height possible. The results for most experiments performed reveal that ultrafiltration rate (UFR) reaches a peak and then declines as the collection receptacle is lowered further. There is also a decline in pre-filter blood flow preceding the peak in UFR. At lower blood flow, UFR decreases for the same transmembrane pressure (TMP). Therefore, as ultrafiltrate pressure is decreased, the effect of increased TMP on UFR is opposed by the effect of decreased blood flow, which decreases UFR. The implication of this in clinical medicine is that one may need to empirically test UFR in a CAVH system in positions other than the very lowest position.

Original languageEnglish (US)
JournalASAIO Journal
Volume39
Issue number3
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Hemofiltration
Ultrafiltration
Pressure
Blood
Networks (circuits)
Clinical Medicine
Medicine
Hydraulics
Fluids

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

@article{2f3b5bb88ac140fb818bc4d704c23e0b,
title = "Maximum ultrafiltration rate in continuous arteriovenous hemofiltration does not occur at the lowest level of the ultrafiltrate collection chamber",
abstract = "A common assumption is that increasing transmembrane pressure by lowering the ultrafiltrate receptacle and the accompanying fluid column should always result in increasing ultrafiltration in continuous arteriovenous hemofiltration (CAVH) systems. To test this assumption, CAVH circuits were operated in vitro with use of a recirculating apparatus with an adjustable elevated reservoir. Hydraulic operational characteristics were studied in a variety of CAVH circuits, lowering the height of the ultrafiltrate column stepwise until it was at the lowest height possible. The results for most experiments performed reveal that ultrafiltration rate (UFR) reaches a peak and then declines as the collection receptacle is lowered further. There is also a decline in pre-filter blood flow preceding the peak in UFR. At lower blood flow, UFR decreases for the same transmembrane pressure (TMP). Therefore, as ultrafiltrate pressure is decreased, the effect of increased TMP on UFR is opposed by the effect of decreased blood flow, which decreases UFR. The implication of this in clinical medicine is that one may need to empirically test UFR in a CAVH system in positions other than the very lowest position.",
author = "Randall Jenkins and B. Chen and Funk, {J. E.}",
year = "1993",
doi = "10.1097/00002480-199307000-00095",
language = "English (US)",
volume = "39",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Maximum ultrafiltration rate in continuous arteriovenous hemofiltration does not occur at the lowest level of the ultrafiltrate collection chamber

AU - Jenkins, Randall

AU - Chen, B.

AU - Funk, J. E.

PY - 1993

Y1 - 1993

N2 - A common assumption is that increasing transmembrane pressure by lowering the ultrafiltrate receptacle and the accompanying fluid column should always result in increasing ultrafiltration in continuous arteriovenous hemofiltration (CAVH) systems. To test this assumption, CAVH circuits were operated in vitro with use of a recirculating apparatus with an adjustable elevated reservoir. Hydraulic operational characteristics were studied in a variety of CAVH circuits, lowering the height of the ultrafiltrate column stepwise until it was at the lowest height possible. The results for most experiments performed reveal that ultrafiltration rate (UFR) reaches a peak and then declines as the collection receptacle is lowered further. There is also a decline in pre-filter blood flow preceding the peak in UFR. At lower blood flow, UFR decreases for the same transmembrane pressure (TMP). Therefore, as ultrafiltrate pressure is decreased, the effect of increased TMP on UFR is opposed by the effect of decreased blood flow, which decreases UFR. The implication of this in clinical medicine is that one may need to empirically test UFR in a CAVH system in positions other than the very lowest position.

AB - A common assumption is that increasing transmembrane pressure by lowering the ultrafiltrate receptacle and the accompanying fluid column should always result in increasing ultrafiltration in continuous arteriovenous hemofiltration (CAVH) systems. To test this assumption, CAVH circuits were operated in vitro with use of a recirculating apparatus with an adjustable elevated reservoir. Hydraulic operational characteristics were studied in a variety of CAVH circuits, lowering the height of the ultrafiltrate column stepwise until it was at the lowest height possible. The results for most experiments performed reveal that ultrafiltration rate (UFR) reaches a peak and then declines as the collection receptacle is lowered further. There is also a decline in pre-filter blood flow preceding the peak in UFR. At lower blood flow, UFR decreases for the same transmembrane pressure (TMP). Therefore, as ultrafiltrate pressure is decreased, the effect of increased TMP on UFR is opposed by the effect of decreased blood flow, which decreases UFR. The implication of this in clinical medicine is that one may need to empirically test UFR in a CAVH system in positions other than the very lowest position.

UR - http://www.scopus.com/inward/record.url?scp=0027377889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027377889&partnerID=8YFLogxK

U2 - 10.1097/00002480-199307000-00095

DO - 10.1097/00002480-199307000-00095

M3 - Article

VL - 39

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -